Thus, TRPV4 inhibitors could suppress photoreceptor death in retinal detachment, and targeting TRPV4 in Müller glial might represent a novel therapeutic target for the prevention of photoreceptor cell death after retinal detachment. This evidence concerns the gene TRPV4 and retinal detachment.